A study into the long-term health impacts of coronavirus, led by experts from the University of Leicester, Imperial College ...

A woman presents with exertional dyspnea, wheezing, and intermittent dry cough, which has been ongoing for over the past 10 ...

Abnormally high levels of lung-injury biomarkers in the blood after COVID-19 infection may flag patients at risk for ongoing lung disease, an Imperial College London–led study suggests.

JAMA named nine of the most influential studies of 2025, including three in neurology. Medscape interviews the researchers to explore the findings and what they could mean for brain health.

Antifibrotic treatments have similar effects in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis.

AstraZeneca has had a setback in its late-stage oncology pipeline, after AKT inhibitor ceralasertib, given in combination with cancer immunotherapy Imfinzi, failed to extend survival in a lung cancer ...

Despite the development of cutting-edge genetic testing techniques and considerable progress in our understanding of the genetic basis of idiopathic pulmonary fibrosis (IPF), missing heritability and ...